479 related articles for article (PubMed ID: 12910597)
1. [Clinical picture of Herpesviridae infections among immunocompromised patients: bone marrow and solid organ transplants recipients].
Simon K; Dziemianko I
Przegl Epidemiol; 2003; 57(2):289-97. PubMed ID: 12910597
[TBL] [Abstract][Full Text] [Related]
2. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
3. DNA viruses (CMV, EBV, and the herpesviruses).
Zamora MR
Semin Respir Crit Care Med; 2011 Aug; 32(4):454-70. PubMed ID: 21858750
[TBL] [Abstract][Full Text] [Related]
4. Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients.
Saral R; Burns WH; Prentice HG
Clin Haematol; 1984 Oct; 13(3):645-60. PubMed ID: 6094062
[TBL] [Abstract][Full Text] [Related]
5. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
Carratalà J; Montejo M; Pérez-Romero P
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
[TBL] [Abstract][Full Text] [Related]
7. Oral manifestations of viral infections in immunocompromised patients.
Schubert MM
Curr Opin Dent; 1991 Aug; 1(4):384-97. PubMed ID: 1666308
[TBL] [Abstract][Full Text] [Related]
8. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
9. [Human herpesvirus 6 (HHV-6): incidence in healthy blood donors and in patients with acute infections caused by other herpes viruses].
Larcher C; Huemer HP; Hönlinger M; Margreiter R; Dierich MP
Wien Klin Wochenschr; 1989 Jun; 101(13):448-50. PubMed ID: 2548350
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 6.
Caserta MT; Mock DJ; Dewhurst S
Clin Infect Dis; 2001 Sep; 33(6):829-33. PubMed ID: 11512088
[TBL] [Abstract][Full Text] [Related]
11. Detection of herpes viruses in children with acute appendicitis.
Katzoli P; Sakellaris G; Ergazaki M; Charissis G; Spandidos DA; Sourvinos G
J Clin Virol; 2009 Apr; 44(4):282-6. PubMed ID: 19233720
[TBL] [Abstract][Full Text] [Related]
12. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.
Razonable RR; Brown RA; Humar A; Covington E; Alecock E; Paya CV;
J Infect Dis; 2005 Oct; 192(8):1331-9. PubMed ID: 16170749
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papilloma virus and human herpes virus types 1-7 in human nasal polyposis.
Zaravinos A; Bizakis J; Spandidos DA
J Med Virol; 2009 Sep; 81(9):1613-9. PubMed ID: 19626617
[TBL] [Abstract][Full Text] [Related]
14. Herpesvirus infections in the immunocompromised patient.
Skinhøj P
Scand J Infect Dis Suppl; 1985; 47():121-7. PubMed ID: 3006227
[TBL] [Abstract][Full Text] [Related]
15. Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV.
Shiley K; Blumberg E
Infect Dis Clin North Am; 2010 Jun; 24(2):373-93. PubMed ID: 20466275
[TBL] [Abstract][Full Text] [Related]
16. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
Engelmann I; Petzold DR; Kosinska A; Hepkema BG; Schulz TF; Heim A
J Med Virol; 2008 Mar; 80(3):467-77. PubMed ID: 18205230
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
[TBL] [Abstract][Full Text] [Related]
18. Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.
Griffiths PD
J Infect Dis; 2002 Oct; 186 Suppl 1():S131-7. PubMed ID: 12353198
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
20. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
